510(k) K011031
K011031 is an FDA 510(k) premarket notification submitted by Vysis for the device "VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT". The FDA issued a decision of Substantially Equivalent on August 3, 2001. The device falls under product code MMW (System, Test, Tumor Marker, Monitoring, Bladder), a Class II device regulated under 21 CFR 866.6010. Vysis has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 3, 2001
- Date Received
- April 5, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Tumor Marker, Monitoring, Bladder
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type